lobbying_activities: 793952

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
793952	0f78db50-8a54-4905-94d2-c69e465f42bf	Q2	AVENUE SOLUTIONS	72111	AETNA	2009	second_quarter	PHA	Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) - generic biologics; H.R. 1204, Community Pharmacy Fairness Act (Weiner) - antitrust exemption for pharmacies; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) - generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) - generic biologics; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office	60000		0	0	2009-07-16T15:46:23-04:00